Reference number : 236-2016-2017-Q4-00026, amendment number : , agreement type : G, recipient legal name : Genge, Angela L, recipient country : CA, recipient province : QC, recipient city : Montreal, recipient postal code : H3A 2T5, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 256250.0, agreement start date : 2017-03-01, agreement end date : 2020-02-29, description english : REALS: Testing the safety of repurposed Enoxacin for the treatment of Amyotrophic Lateral Sclerosis, description french : REALS: Testing the safety of repurposed Enoxacin for the treatment of Amyotrophic Lateral Sclerosis, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2016-17 to 2019-20), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2016-17 à 2019-20), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada